Does CILTACABTAGENE AUTOLEUCEL Cause Hospitalisation? 193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Hospitalisation have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 5.1% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
193
Reports of Hospitalisation with CILTACABTAGENE AUTOLEUCEL
5.1%
of all CILTACABTAGENE AUTOLEUCEL reports
0
Deaths
191
Hospitalizations
How Dangerous Is Hospitalisation From CILTACABTAGENE AUTOLEUCEL?
Of the 193 reports, 191 (99.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
Cranial nerve paralysis (115)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Hospitalisation Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE